performed WES on 15 NECC samples and found that one tumor exhibited a somatic mutation rate more than ten times that of the median for the cohort and that the tumor also contained the pathogenic MSH2 missense mutation (p.G164R) (12). Here, MSH2 is linked to neoplasm.